Standout Papers

Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance 2023 2026 2024192
  1. Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance (2023)
    Xiaowei Liu, Jinen Song et al. Cancer Cell

Immediate Impact

2 from Science/Nature 67 standout
Sub-graph 1 of 22

Citing Papers

A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Thirty years of NRF2: advances and therapeutic challenges
2025 Standout
2 intermediate papers

Works of Jianping Hu being referenced

The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells
2022
Discovery of a First-in-Class Mitogen-Activated Protein Kinase Kinase 1/2 Degrader
2019
and 1 more

Author Peers

Author Last Decade Papers Cites
Jianping Hu 226 29 186 109 12 462
Päivi Turunen 345 56 145 75 14 573
Fiona R. Green 141 43 111 152 13 544
Nelson E. Bruno 199 35 83 73 18 549
Mohamed Saiel Saeed Alhamdani 231 37 117 69 19 504
Janice M. Kraniak 220 14 102 84 15 487
Aurore Devocelle 133 9 174 147 15 482
Yuji Matsuzawa 259 41 60 110 17 495
Valerie Atizado 219 24 121 103 8 479
Ruwen Cui 215 46 99 112 8 460
Graziella Malaponte 241 25 125 69 10 476

All Works

Loading papers...

Rankless by CCL
2026